ZEUS receives FDA EUA approval for SARS-SoV-2 Tests on Dynex Instruments

ZEUS has received FDA authorization to run the ZEUS ELISA SARS-SoV-2 Total Antibody Test System using the Dynex Agility®, Dynex DSX® or Dynex DS2® Automated ELISA Systems.

Learn More.

The SARS-CoV-2 IgG Test System was first granted EUA in October of 2020 to run using the Dynex Agility^® Automated ELISA System. The FDA has extended this EUA to now include the Dynex DS2® and Dynex DSX® instruments.

Learn More.